Last reviewed · How we verify

NCT05184673: MAT

Moderate Aerobic Activity Through Yoga

Completed NA Last updated 1 July 2022
What this trial tests

NA trial testing Behavioral and environmental in Physical Activity in 21 participants. Completed in 28 October 2021.

Timeline
8 June 2021
Primary endpoint
28 October 2021
28 October 2021

Quick facts

Lead sponsorVirginia Polytechnic Institute and State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment21
Start date8 June 2021
Primary completion28 October 2021
Estimated completion28 October 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Virginia Polytechnic Institute and State University

Who can join

Adults 65 to 85, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The 2018 Physical Activity Guidelines for Americans (PAGA) recommend 150 minutes of moderate intensity activity for adult (18 years and older) Americans to promote health. PAGA also recommends that older adults (65+) engage in multicomponent and balance exercises weekly as a way to reduce falls and injuries from falls. This recommendation includes yoga, however, the current research and recommendations on using yoga to meet moderate intensity activity guidelines is limited. This study will utilize heart rate monitoring to determine if certain styles of yoga can be used to meet the PAGA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Virginia Polytechnic Institute and State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05184673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing